159 related articles for article (PubMed ID: 30776480)
21. EphB4 provides survival advantage to squamous cell carcinoma of the head and neck.
Masood R; Kumar SR; Sinha UK; Crowe DL; Krasnoperov V; Reddy RK; Zozulya S; Singh J; Xia G; Broek D; Schönthal AH; Gill PS
Int J Cancer; 2006 Sep; 119(6):1236-48. PubMed ID: 16615113
[TBL] [Abstract][Full Text] [Related]
22. Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.
Hamada K; Oike Y; Ito Y; Maekawa H; Miyata K; Shimomura T; Suda T
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):190-7. PubMed ID: 12588758
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of EphB4 phosphorylation is necessary for esophageal squamous cell carcinoma tumorigenecity.
Hu F; Tao Z; Shen Z; Wang X; Hua F
Tumour Biol; 2014 Jul; 35(7):7225-32. PubMed ID: 24771266
[TBL] [Abstract][Full Text] [Related]
24. Ephrin type-B receptor 4 activation reduces neointimal hyperplasia in human saphenous vein in vitro.
Wong DJ; Lu DY; Protack CD; Kuwahara G; Bai H; Sadaghianloo N; Tellides G; Dardik A
J Vasc Surg; 2016 Mar; 63(3):795-804. PubMed ID: 25446283
[TBL] [Abstract][Full Text] [Related]
25. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
Bai J; Wang YJ; Liu L; Zhao YL
J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
[TBL] [Abstract][Full Text] [Related]
26. Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension.
Crnkovic S; Rittchen S; Jandl K; Gindlhuber J; Zabini D; Mutgan AC; Valzano F; Boehm PM; Hoetzenecker K; Toller W; Veith C; Heinemann A; Schermuly RT; Olschewski A; Marsh LM; Kwapiszewska G
Hypertension; 2023 Feb; 80(2):e17-e28. PubMed ID: 36519465
[TBL] [Abstract][Full Text] [Related]
27. Spatiomechanical Modulation of EphB4-Ephrin-B2 Signaling in Neural Stem Cell Differentiation.
Dong M; Spelke DP; Lee YK; Chung JK; Yu CH; Schaffer DV; Groves JT
Biophys J; 2018 Sep; 115(5):865-873. PubMed ID: 30075851
[TBL] [Abstract][Full Text] [Related]
28. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells.
Foubert P; Silvestre JS; Souttou B; Barateau V; Martin C; Ebrahimian TG; Leré-Déan C; Contreres JO; Sulpice E; Levy BI; Plouët J; Tobelem G; Le Ricousse-Roussanne S
J Clin Invest; 2007 Jun; 117(6):1527-37. PubMed ID: 17510705
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers.
Bhatia S; Sharma J; Bukkapatnam S; Oweida A; Lennon S; Phan A; Milner D; Uyanga N; Jimeno A; Raben D; Somerset H; Heasley L; Karam SD
Clin Cancer Res; 2018 Sep; 24(18):4539-4550. PubMed ID: 29848571
[No Abstract] [Full Text] [Related]
30. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.
Nakada M; Drake KL; Nakada S; Niska JA; Berens ME
Cancer Res; 2006 Sep; 66(17):8492-500. PubMed ID: 16951161
[TBL] [Abstract][Full Text] [Related]
31. PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.
Noberini R; Mitra S; Salvucci O; Valencia F; Duggineni S; Prigozhina N; Wei K; Tosato G; Huang Z; Pasquale EB
PLoS One; 2011; 6(12):e28611. PubMed ID: 22194865
[TBL] [Abstract][Full Text] [Related]
32. The protective role of Ephrin-B2/EphB4 signaling in osteogenic differentiation under inflammatory environment.
Qu F; Song Y; Wu Y; Huang Y; Zhong Q; Zhang Y; Fan Z; Xu C
Exp Cell Res; 2021 Mar; 400(2):112505. PubMed ID: 33516666
[TBL] [Abstract][Full Text] [Related]
33. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
Noren NK; Foos G; Hauser CA; Pasquale EB
Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147
[TBL] [Abstract][Full Text] [Related]
34. Reduction of Akt2 inhibits migration and invasion of glioma cells.
Zhang B; Gu F; She C; Guo H; Li W; Niu R; Fu L; Zhang N; Ma Y
Int J Cancer; 2009 Aug; 125(3):585-95. PubMed ID: 19330838
[TBL] [Abstract][Full Text] [Related]
35. Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.
Kuang SQ; Bai H; Fang ZH; Lopez G; Yang H; Tong W; Wang ZZ; Garcia-Manero G
Blood; 2010 Mar; 115(12):2412-9. PubMed ID: 20061560
[TBL] [Abstract][Full Text] [Related]
36. Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers.
Liersch-Löhn B; Slavova N; Buhr HJ; Bennani-Baiti IM
Int J Cancer; 2016 Mar; 138(5):1220-31. PubMed ID: 26414866
[TBL] [Abstract][Full Text] [Related]
37. Preliminary identification of potential PDZ-domain proteins downstream of ephrin B2 during osteoclast differentiation of RAW264.7 cells.
Mao Y; Huang X; Zhao J; Gu Z
Int J Mol Med; 2011 May; 27(5):669-77. PubMed ID: 21373749
[TBL] [Abstract][Full Text] [Related]
38. EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2.
Héroult M; Schaffner F; Pfaff D; Prahst C; Kirmse R; Kutschera S; Riedel M; Ludwig T; Vajkoczy P; Graeser R; Augustin HG
Mol Cancer Res; 2010 Oct; 8(10):1297-309. PubMed ID: 21047731
[TBL] [Abstract][Full Text] [Related]
39. The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand.
Yang NY; Lopez-Bergami P; Goydos JS; Yip D; Walker AM; Pasquale EB; Ethell IM
Pigment Cell Melanoma Res; 2010 Oct; 23(5):684-7. PubMed ID: 20649938
[No Abstract] [Full Text] [Related]
40. Sinusoidal ephrin receptor EPHB4 controls hematopoietic progenitor cell mobilization from bone marrow.
Kwak H; Salvucci O; Weigert R; Martinez-Torrecuadrada JL; Henkemeyer M; Poulos MG; Butler JM; Tosato G
J Clin Invest; 2016 Dec; 126(12):4554-4568. PubMed ID: 27820703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
